Trial intelligence / Profile preview

LNG IUS Bleeding Profiles in Transition to Menopause

NCT00185458Phase 3Completed

Sponsor
Bayer
Start
May 2000
Primary completion
May 2008
Modality
Small Molecules
Countries
4
01

Overview

A Phase 3 trial of levonorgestrel intrauterine system in menopause, sponsored by Bayer. Started May 2000; status: completed.

02

Drugs

levonorgestrel intrauterine system
03

Conditions

menopause

Beyond the preview

Go deeper on NCT00185458.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00185458.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call